Cargando…

Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)

Patient care in a neurointensive care unit (neuro-ICU) is challenging. Multidrug-resistant organisms (MDROs) are increasingly common in the routine clinical practice. We evaluated the impact of infection with MDROs on outcomes in patients with subarachnoid hemorrhage (SAH). A single-center retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rhim, Ha-Young, Won, Sae-Yeon, Kashefiolasl, Sepide, Brawanski, Nina, Hattingen, Elke, Berkefeld, Joachim, Seifert, Volker, Konczalla, Juergen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050277/ https://www.ncbi.nlm.nih.gov/pubmed/33859304 http://dx.doi.org/10.1038/s41598-021-87863-y

Ejemplares similares

Does aneurysm side influence the infarction side and patients´ outcome after subarachnoid hemorrhage?
por: Brawanski, Nina, et al.
Publicado: (2019)

Impact of COVID-19 Pandemic on Treatment Management and Clinical Outcome of Aneurysmal Subarachnoid Hemorrhage – A Single-Center Experience
por: Kashefiolasl, Sepide, et al.
Publicado: (2022)

Statins Improve Clinical Outcome After Non-aneurysmal Subarachnoid Hemorrhage: A Translational Insight From a Systematic Review of Experimental Studies
por: Kashefiolasl, Sepide, et al.
Publicado: (2021)

MRI-detection rate and incidence of lumbar bleeding sources in 190 patients with non-aneurysmal SAH
por: Kashefiolasl, Sepide, et al.
Publicado: (2017)

Short- and Long-Term Effects of Rehabilitation after Perimesencephalic Subarachnoid Hemorrhage
por: Schmitz, Jens, et al.
Publicado: (2021)

Differences in bleeding patterns and outcome after intracerebral hemorrhage due to vascular malformations
por: Dinc, Nazife, et al.
Publicado: (2019)

Impact of COVID-19 pandemic on treatment management and clinical outcome of aneurysmal subarachnoid hemorrhage – A single center experience
por: Kashefiolasl, S., et al.
Publicado: (2022)

Invasive Diagnostic and Therapeutic Management of Cerebral VasoSpasm after Aneurysmal Subarachnoid Hemorrhage (IMCVS)—A Phase 2 Randomized Controlled Trial
por: Vatter, Hartmut, et al.
Publicado: (2022)

Short- and midterm outcome of ruptured and unruptured intracerebral wide-necked aneurysms with microsurgical treatment
por: Won, Sae-Yeon, et al.
Publicado: (2021)

Levosimendan as a therapeutic strategy to prevent neuroinflammation after aneurysmal subarachnoid hemorrhage?
por: Wanderer, Stefan, et al.
Publicado: (2022)

Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
por: Schneider, U.C., et al.
Publicado: (2018)

The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage
por: Wanderer, Stefan, et al.
Publicado: (2020)

Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Weiland, Judith, et al.
Publicado: (2021)

The clinical relevance of ABO blood type in 100 patients with acute subdural hematoma
por: Dubinski, Daniel, et al.
Publicado: (2018)

Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Ran, Kathleen R, et al.
Publicado: (2023)

Initial severity of aneurysmal subarachnoid hemorrhage (SAH): Trend over time
por: Sung, Seung Bin, et al.
Publicado: (2022)

Follow-up of Vasospasm by Transcranial Doppler Sonography (TCD) in Subarachnoid Hemorrhage (SAH)
por: Djelilovic-Vranic, Jasminka, et al.
Publicado: (2017)

Exome sequencing study revealed novel susceptibility loci in subarachnoid hemorrhage (SAH)
por: Hao, Xiwa, et al.
Publicado: (2020)

Non-aneurysmal non-traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients
por: Konczalla, Juergen, et al.
Publicado: (2014)

Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2021)

DIagnostic Subdural EEG electrodes And Subdural hEmatoma (DISEASE): a study protocol for a prospective nonrandomized controlled trial
por: Won, Sae-Yeon, et al.
Publicado: (2020)

Outcomes of spontaneous subarachnoid hemorrhage (sah) in neurocritical care unit: a multicenter study
por: Iglesias Posadilla, D, et al.
Publicado: (2015)

First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH)
por: Lilla, Nadine, et al.
Publicado: (2017)

Janus Faced HMGB1 and Post-Aneurysmal Subarachnoid Hemorrhage (aSAH) Inflammation
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2022)

Clustering of serum biomarkers involved in post-aneurysmal subarachnoid hemorrhage (aSAH) complications
por: Fischer, Igor, et al.
Publicado: (2023)

Detecting Sepsis in Patients with Severe Subarachnoid Hemorrhage during Critical Care
por: Flinspach, Armin Niklas, et al.
Publicado: (2022)

Cerebral foreign body granuloma in brain triggering generalized seizures without obvious craniocerebral injury: A case report and review of the literature
por: Brawanski, Nina, et al.
Publicado: (2016)

Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2018)

919. Understanding Intermittent Detection of Multidrug-Resistant Organisms (MDROs) in Rectally Colonized Patients
por: Sansom, Sarah, et al.
Publicado: (2020)

Changes in the C-type Natriuretic peptide (CNP) and NO derivatives in the plasma and CSF of the patients with subarachnoid hemorrhage (SAH)
por: Ikeda, K, et al.
Publicado: (2000)

Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH)
por: Heinz, Rebecca, et al.
Publicado: (2021)

1764. The Gut: A Veiled Reservoir for Multidrug-resistant Organisms (MDROs) Below the Tip of the Iceberg
por: Shimasaki, Teppei, et al.
Publicado: (2018)

1687. High-Rates of Candida auris Carriage and Co-Colonization with Multidrug-Resistant Organisms (MDROs)
por: Barza, Ruby, et al.
Publicado: (2019)

Should endovascular therapy for cerebral vasospasm coincide with hypervolemic-hypertensive therapy (HT) in aneurysmal subarachnoid hemorrhage (SAH)?
por: Liopyris, P, et al.
Publicado: (1999)

Monitoring of hypervolemic hemodilution and hypertensive (HHH) therapy in subarachnoid hemorrhage (SAH) patients with pulmonary artery catheter (PAC)
por: Nates, JL, et al.
Publicado: (1998)

Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2017)

Intracranial Venous Alteration in Patients With Aneurysmal Subarachnoid Hemorrhage: Protocol for the Prospective and Observational SAH Multicenter Study (SMS)
por: Umana, Giuseppe E., et al.
Publicado: (2022)

TLR4-Pathway-Associated Biomarkers in Subarachnoid Hemorrhage (SAH): Potential Targets for Future Anti-Inflammatory Therapies
por: Heinz, Rebecca, et al.
Publicado: (2022)

Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies
por: Jin, Jing, et al.
Publicado: (2022)

A Paravermal Trans-Cerebellar Approach to the Posterior Fossa Tumor Causes Hypertrophic Olivary Degeneration by Dentate Nucleus Injury
por: Schaller-Paule, Martin A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mp6obaqv9u327d0c63qsf6jlud